Correlation Between Molecular Partners and Genenta Science
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Genenta Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Genenta Science into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Genenta Science SpA, you can compare the effects of market volatilities on Molecular Partners and Genenta Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Genenta Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Genenta Science.
Diversification Opportunities for Molecular Partners and Genenta Science
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Molecular and Genenta is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Genenta Science SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genenta Science SpA and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Genenta Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genenta Science SpA has no effect on the direction of Molecular Partners i.e., Molecular Partners and Genenta Science go up and down completely randomly.
Pair Corralation between Molecular Partners and Genenta Science
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 0.7 times more return on investment than Genenta Science. However, Molecular Partners AG is 1.43 times less risky than Genenta Science. It trades about -0.06 of its potential returns per unit of risk. Genenta Science SpA is currently generating about -0.1 per unit of risk. If you would invest 583.00 in Molecular Partners AG on December 4, 2024 and sell it today you would lose (80.00) from holding Molecular Partners AG or give up 13.72% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Molecular Partners AG vs. Genenta Science SpA
Performance |
Timeline |
Molecular Partners |
Genenta Science SpA |
Molecular Partners and Genenta Science Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Molecular Partners and Genenta Science
The main advantage of trading using opposite Molecular Partners and Genenta Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Genenta Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genenta Science will offset losses from the drop in Genenta Science's long position.Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Genenta Science vs. Molecular Partners AG | Genenta Science vs. MediciNova | Genenta Science vs. Anebulo Pharmaceuticals | Genenta Science vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |